The American Journal of Hematology turns 40 von Brugnara, Carlo

Volltext

As I recall the beginning of the American journal of hematology forty years ago von Prasad, Ananda S.

Volltext

American Journal of Hematology, getting ready for the 40th birthday in 2016 von Brugnara, Carlo

Volltext

Continuing medical education activity in American Journal of Hematology von TEFFERI, Ayalew, GARCIA-MANERO, Guillermo

Volltext

Continuing medical education program i n American Journal of Hematology von TEFFERI, Ayalew

Volltext

The American Journal of Hematology, 2011 and beyond von Brugnara, Carlo, Tefferi, Ayalew

Volltext

The American Journal of Hematology in 2007 von Brugnara, Carlo

Volltext

The American Journal of Hematology would like to thank the colleagues who have spent an enormous amount of time and energy reading and critiquing manuscripts published in 2013 and 2014. Below we list those who have served as ad hoc reviewers for the journal for these years. We apologize in advance if you have reviewed for us and your name is not listed

Volltext

The American Journal of Hematology would like to thank the colleagues who have spent an enormous amount of time and energy reading and critiquing submitted manuscripts. Below we list those who have served as ad hoc reviewers for the journal in 2011 and 2012

Volltext

The first thirty years of the American Journal of Hematology: My recollections von Prasad, Ananda S.

Volltext

Diskette submission instruction American journal of hematology

Volltext

Wiley relaunches American Journal of Hematology

Volltext

American journal of hematology 1979 reviewers

Volltext

RETRACTION: A predictive model of herpes zoster after allogeneic hematopoietic stem cell transplantation: VZV reactivation following antiviral prophylaxis discontinuation

Volltext

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up von Gambacorti‐Passerini, Carlo, Brümmendorf, Tim H., Kim, Dong‐Wook, Turkina, Anna G., Masszi, Tamas, Assouline, Sarit, Durrant, Simon, Kantarjian, Hagop M., Khoury, H. Jean, Zaritskey, Andrey, Shen, Zhi‐Xiang, Jin, Jie, Vellenga, Edo, Pasquini, Ricardo, Mathews, Vikram, Cervantes, Francisco, Besson, Nadine, Turnbull, Kathleen, Leip, Eric, Kelly, Virginia, Cortes, Jorge E.

Volltext

Evidence of selective reporting bias in hematology journals: A systematic review von Wayant, Cole, Scheckel, Caleb, Hicks, Chandler, Nissen, Timothy, Leduc, Linda, Som, Mousumi, Vassar, Matt

Volltext

Deferiprone‐induced agranulocytosis: 20 years of clinical observations von Tricta, Fernando, Uetrecht, Jack, Galanello, Renzo, Connelly, John, Rozova, Anna, Spino, Michael, Palmblad, Jan

Volltext

Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia von Gambacorti‐Passerini, Carlo, Cortes, Jorge E., Lipton, Jeff H., Dmoszynska, Anna, Wong, Raymond S., Rossiev, Victor, Pavlov, Dmitri, Gogat Marchant, Karin, Duvillié, Ladan, Khattry, Navin, Kantarjian, Hagop M., Brümmendorf, Tim H.

Volltext

Long‐term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib von Cortes, Jorge E., Khoury, Hanna J., Kantarjian, Hagop M., Lipton, Jeff H., Kim, Dong‐Wook, Schafhausen, Philippe, Matczak, Ewa, Leip, Eric, Noonan, Kay, Brümmendorf, Tim H., Gambacorti‐Passerini, Carlo

Volltext

The glomerulopathy of sickle cell disease von Ataga, Kenneth I., Derebail, Vimal K., Archer, David R.

Volltext